Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.
Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC. Rijal S, et al. Among authors: dorlo tp. Clin Infect Dis. 2013 Jun;56(11):1530-8. doi: 10.1093/cid/cit102. Epub 2013 Feb 20. Clin Infect Dis. 2013. PMID: 23425958
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177 Lu-PSMA-617 in prostate cancer patients.
Siebinga H, Privé BM, Peters SMB, Nagarajah J, Dorlo TPC, Huitema ADR, de Wit-van der Veen BJ, Hendrikx JJMA. Siebinga H, et al. CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1060-1071. doi: 10.1002/psp4.12914. Epub 2023 Feb 9. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36760133 Free PMC article.
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
Verrest L, Roseboom IC, Wasunna M, Mbui J, Njenga S, Musa AM, Olobo J, Mohammed R, Ritmeijer K, Chu WY, Huitema ADR, Solomos A, Alves F, Dorlo TPC. Verrest L, et al. J Antimicrob Chemother. 2023 Nov 6;78(11):2702-2714. doi: 10.1093/jac/dkad286. J Antimicrob Chemother. 2023. PMID: 37726401 Free PMC article. Clinical Trial.
Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication.
Hooijberg F, Layegh Z, Leeuw M, Boekel L, van den Berg SPH, Ruwaard J, Bastida C, Huitema ADR, Pel S, Elkayam O, de Vries A, Nurmohamed M, Rispens T, Dorlo TPC, Wolbink G. Hooijberg F, et al. Ther Drug Monit. 2024 Jun 1;46(3):410-414. doi: 10.1097/FTD.0000000000001168. Epub 2024 Jan 24. Ther Drug Monit. 2024. PMID: 38287880 Clinical Trial.
[Miltefosine: a new remedy for leishmaniasis].
Dorlo TP, Eggelte TA, Beijnen JH, de Vries PJ. Dorlo TP, et al. Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2697-701. Ned Tijdschr Geneeskd. 2006. PMID: 17194005 Review. Dutch.
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.
Dorlo TP, van Thiel PP, Huitema AD, Keizer RJ, de Vries HJ, Beijnen JH, de Vries PJ. Dorlo TP, et al. Antimicrob Agents Chemother. 2008 Aug;52(8):2855-60. doi: 10.1128/AAC.00014-08. Epub 2008 Jun 2. Antimicrob Agents Chemother. 2008. PMID: 18519729 Free PMC article. Clinical Trial.
127 results